NEWS
【Event】SOSV Health Tech Matchup – Feb 26-Mar 8, 2024
we’ve been approved for participation of 2024 Health Tech VC-Founder Matchup. What is SOSV Health Tech M
Happy new year 2024
To all, Happy New Year! As we embark on a new year, it is the season to take new steps with renewed hearts. We
We will talk a Lightning Talk at KLSAP2023
About The Kansai Life Science Accelerator Program (KLSAP) was launched in 2020 to provide Japanese startups wi
Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.
(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further s
Top 10 Finalists 「DWEN Dream Tech Contest」
Our company was selected as a finalist in the Dell Women Entrepreneur Business Contest 2023, a business contes
We’re able to obtain an Unique Entity Identifier.
On May 16, 2023, we have obtained a Unique Entity Identifier (UEI), which allows us to receive grants and assi
【Event】SOSV Health Tech Matchup – Feb 26-Mar 8, 2024
we’ve been approved for participation of 2024 Health Tech VC-Founder Matchup.
What is SOSV Health Tech Matchup?
Based on our past experience conducting matchups, we expect that this virtual event will bring together 500 startups and 300 investors for 1:1 meetings online over two weeks, scheduled at mutually convenient times.
In 2023, SOSV Matchups generated over 5,000 one-on-one meetings in Health Tech, Climate and Industrial Tech, receiving high praise from over 2,000 participants:
“6 months of deal flow in a week” (investor)
“Right stage and areas. High quality meetings.” (investor)
“The most value we’ve ever received.” (startup)
“More VC meetings in a week than in the past 6 months.” (startup)
Happy new year 2024
To all, Happy New Year! As we embark on a new year, it is the season to take new steps with renewed hearts. We express our gratitude for the past and, with expectations for the future, we kindly ask for your continued support in the coming year.
We have had a fulfilling year, thanks to all of you. We deeply appreciate the support and cooperation of our customers and business partners, which have made this possible.
In the coming year, we pledge to work even harder for evolution and growth. We will strive to provide valuable services and products to our customers, and we look forward to your continued patronage.
Thank you for your unwavering support. Wishing you a wonderful year ahead.
Tomoko Fujino/CEO
We will talk a Lightning Talk at KLSAP2023
About
The Kansai Life Science Accelerator Program (KLSAP) was launched in 2020 to provide Japanese startups with an online acceleration program by the U.S. accelerator California Life Sciences (CLS) to support their overseas business development.
The KLSAP was launched in 2020 to provide an online acceleration program for Japanese startups by the U.S. accelerator California Life Sciences (CLS) to support global business development.
The 4th KLSAP, will host a pitch competition among 10 companies for only 3 opportunities to participate in the accelerator program. Please come and watch the excited pitches of the companies live.
Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.
(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further spread of real-time 2D to 3D technology that creates stereoscopic images using AI to generate medical-related images using artificial intelligence technology in the field of digital health, as well as joint research and development with the National Cancer Center Hospital, (Head Office: Hachioji City, Tokyo; President: Tomoko Fujino), which is also engaged in joint research and development with the National Cancer Center Central Hospital, announces that it has established a local subsidiary, “NOVIUS Company, Ltd.
Top 10 Finalists 「DWEN Dream Tech Contest」
Our company was selected as a finalist in the Dell Women Entrepreneur Business Contest 2023, a business contest sponsored by Dell Technologies, Inc. that aims to discover and support outstanding women entrepreneurs who are adopting technology as a growth strategy.
We’re able to obtain an Unique Entity Identifier.
On May 16, 2023, we have obtained a Unique Entity Identifier (UEI), which allows us to receive grants and assistance from the U.S. federal government.
We will gradually apply to various national agencies, including U.S. grants.
